The Unlikely Alliance: How a Trump-Era Policy is Bridging the Health Care Divide
There’s something almost poetic about a Trump-era health care policy gaining traction in both red and blue states. It’s like watching political rivals reluctantly agree on the same dance move at a party—awkward yet undeniably fascinating. The policy in question? Individual Coverage Health Reimbursement Arrangements, or ICHRAs. What makes this particularly fascinating is how it’s becoming a rare point of bipartisan agreement in an era where even the color of the sky feels partisan.
Personally, I think the rise of ICHRAs speaks to a deeper truth: when it comes to health care, pragmatism often trumps ideology. With Obamacare enrollment dropping by over 1 million this year, states are scrambling for solutions. ICHRAs, which allow employers to give workers tax-exempt subsidies to buy ACA plans, are emerging as a stopgap. But here’s the kicker: what many people don’t realize is that this policy isn’t just about keeping costs down—it’s about political survival. Both parties are using it to claim they’re addressing health care affordability without admitting they’re building on each other’s ideas.
The Bipartisan Appeal: Why ICHRAs Are a Political Unicorn
What’s striking about ICHRAs is how neatly they fit into both parties’ narratives. For Democrats, it’s a way to shore up the ACA marketplace. For Republicans, it’s a market-based solution that puts money directly in consumers’ hands. In my opinion, this duality is why it’s gaining traction. It’s like a policy chameleon, blending into whatever ideological landscape it’s placed in.
Take Connecticut’s Democratic Governor Ned Lamont, who’s pushing for tax credits to incentivize small businesses to adopt ICHRAs. His reasoning? It helps small businesses manage health costs while keeping people off Medicaid, which saves the state money. Meanwhile, in Ohio, Republican Rep. Meredith Craig is championing the same policy, framing it as a way to move people from Medicaid to private insurance. If you take a step back and think about it, both are essentially selling the same policy but wrapping it in different political packaging.
The Insurer Angle: A Pragmatic Push
One thing that immediately stands out is the role insurers are playing in this drama. Companies like Oscar Health and Centene are lobbying hard for ICHRAs, seeing them as a lifeline in the post-subsidy era. With enhanced ACA subsidies expiring at the end of 2025, insurers are desperate for alternatives to keep people insured. ICHRAs offer a way to funnel customers into the individual market while maintaining their profit margins.
But here’s where it gets interesting: insurers are framing this as a win for consumers, not just their bottom line. Cathy Grason of Oscar Health argues that ICHRAs give people more affordable options. While there’s truth to that, it’s also a strategic move to stay relevant in a shifting market. What this really suggests is that insurers are as much political players as they are health care providers.
The Limitations: Why ICHRAs Aren’t a Silver Bullet
For all the hype, ICHRAs aren’t a cure-all. A detail that I find especially interesting is how they can actually disadvantage workers. If an employer offers an ICHRA, employees often lose access to Obamacare subsidies, which might be more generous depending on their income. Plus, ICHRAs don’t address the root cause of rising health care costs—they just shuffle the deck chairs.
Health policy analyst Louise Norris puts it bluntly: “You can’t solve that problem by shifting people from the group market to the individual market or vice versa.” This raises a deeper question: are we just kicking the can down the road? I’m not convinced ICHRAs are a long-term solution, but they’re a symptom of a larger trend—patchwork policies in the absence of comprehensive reform.
The Future: A Temporary Fix or Lasting Change?
The momentum behind ICHRAs is undeniable. Six states are considering tax credit bills, and the National Conference of Insurance Legislators is working on a model law to make it easier for others to follow suit. But here’s my take: while ICHRAs might stick around, they’re more of a Band-Aid than a revolution.
What many people don’t realize is that the real story here isn’t the policy itself—it’s the desperation driving its adoption. Both parties are grasping for anything that looks like progress on health care affordability. ICHRAs are convenient because they don’t require anyone to admit they’re wrong or compromise too much.
Final Thoughts: The Politics of Pragmatism
If there’s one takeaway from the ICHRA saga, it’s this: in health care, politics often gets in the way of solutions, but sometimes it’s the only way to get anything done. ICHRAs are a testament to the power of pragmatism—even if it’s begrudging.
From my perspective, the real question isn’t whether ICHRAs will work, but what they say about our political system. Are we so gridlocked that we’ll only accept policies that don’t challenge our core beliefs? Or is this the start of a new era where both parties find common ground on health care? Personally, I’m not holding my breath for the latter. But for now, ICHRA’s rise is a fascinating study in how politics and policy intersect—and how even the most unlikely ideas can find their moment.
